Profile data is unavailable for this security.
About the company
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.
- Revenue in USD (TTM)20.08bn
- Net income in USD2.90bn
- Incorporated1979
- Employees53.00k
- LocationBoston Scientific Corp300 Boston Scientific WayMARLBOROUGH 01752-1234United StatesUSA
- Phone+1 (302) 636-5400
- Fax+1 (302) 636-5454
- Websitehttps://www.bostonscientific.com/en-US/Home.html
Mergers & acquisitions
| Acquired company | BSX:NYQ since announced | Transaction value |
|---|---|---|
| Penumbra Inc | -20.79% | 15.05bn |
| Valencia Technologies Corp | -23.96% | -- |
| Nalu Medical Inc | -24.06% | 533.00m |
| Elutia Inc-BioEnvelope Business | -31.34% | 88.00m |
| SoniVie Ltd | -28.46% | 540.00m |
